NovoCure Limited (NVCR) financial statements (2021 and earlier)

Company profile

Business Address NO. 4 THE FORUM
ST. HELIER, JE2 4UF
State of Incorp.
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments326246183220269
Cash and cash equivalents17714179100119
Short-term investments149105105120150
Restricted cash and investments22200
Receivables5937306 
Inventory, net of allowances, customer advances and progress billings2423222614
Inventory2423222614
Prepaid expense24321
Other undisclosed current assets27115810
Total current assets:440321245262294
Noncurrent Assets
Property, plant and equipment989107
Other noncurrent assets53221
Defined benefit plan, assets for plan benefits64
Other undisclosed noncurrent assets257932
Total noncurrent assets:4018202013
TOTAL ASSETS:479340265282307
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6343312626
Accounts payable3727171817
Accrued liabilities50001
Employee-related liabilities21171388
Debt 0000
Other undisclosed current liabilities242120113
Total current liabilities:8665503729
Noncurrent Liabilities
Long-term debt and lease obligation149149979623
Long-term debt, excluding current maturities149149979623
Liabilities, other than long-term debt2413243
Contract with customer, liability8 
Liability, pension and other postretirement and postemployment benefits1612   
Other liabilities01243
Other undisclosed noncurrent liabilities20232
Total noncurrent liabilities:17516310210328
Total liabilities:26222815214057
Stockholders' equity
Stockholders' equity attributable to parent218112114142251
Additional paid in capital871757697664640
Accumulated other comprehensive loss(3)(1)(1)(2)(2)
Accumulated deficit(651)(644)(582)(520)(388)
Total stockholders' equity:218112114142251
TOTAL LIABILITIES AND EQUITY:479340265282307

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues3512481778333
Revenue, net1778333
Cost of revenue(89)(80)(56)(40)(21)
Cost of goods and services sold(0)(2)(7)(10)(1)
Other undisclosed gross profit   (6) 
Gross profit:2631681213712
Operating expenses(264)(202)(161)(152)(116)
Operating loss:(1)(34)(39)(115)(104)
Interest and debt expense(8)(12)(9)(6)(3)
Loss from continuing operations before income taxes:(9)(46)(48)(121)(107)
Income tax expense (benefit)2(18)(13)(10)(4)
Net loss available to common stockholders, diluted:(7)(64)(62)(132)(112)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(7)(64)(62)(132)(112)
Other comprehensive income (loss)(1)(0)1(0)(2)
Comprehensive loss, net of tax, attributable to parent:(9)(64)(61)(132)(113)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: